老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

26.31
-1.1000-4.01%
盘后：26.20-0.1100-0.42%19:56 EDT
成交量：390.58万
成交额：1.04亿
市值：24.83亿
市盈率：-4.48
高：27.89
开：27.41
低：26.00
收：27.41
数据加载中...
总览公司新闻公告
2020/05/13

重要事件披露

8-K - Current report
2020/05/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/01

重要事件披露

Current report, items 3.02, 8.01, and 9.01
2020/03/06

重要事件披露

8-K - Current report
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02, 7.01, 8.01, and 9.01
2020/01/09

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/01/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
更多